Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| 1 |
Capital One
COF
|
+$445M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$405M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$387M |
| 4 |
Johnson & Johnson
JNJ
|
+$256M |
| 5 |
Procter & Gamble
PG
|
+$170M |
Top Sells
| 1 |
DFS
Discover Financial Services
DFS
|
+$536M |
| 2 |
NVIDIA
NVDA
|
+$471M |
| 3 |
X
US Steel
X
|
+$421M |
| 4 |
JPMorgan Chase
JPM
|
+$237M |
| 5 |
Deere & Co
DE
|
+$235M |
Sector Composition
| 1 | Technology | 20.97% |
| 2 | Financials | 18.52% |
| 3 | Industrials | 12.24% |
| 4 | Consumer Discretionary | 10.39% |
| 5 | Healthcare | 9.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
351
ADT
ADT
$7.07B
| $270M | 0.06% |
31,869,188
+5,791,257
| +22% | +$49.1M |
|
352
Jazz Pharmaceuticals
JAZZ
$7.88B
| $269M | 0.06% |
2,537,837
+209,407
| +9% | +$22.2M |
|
353
Gartner
IT
$18.7B
| $267M | 0.06% |
661,513
+17,150
| +3% | +$6.93M |
|
354
Coterra Energy
CTRA
$18.2B
| $267M | 0.06% |
10,504,042
+55,219
| +0.5% | +$1.4M |
|
355
Vertex Pharmaceuticals
VRTX
$101B
| $265M | 0.06% |
596,227
-9,652
| -2% | -$4.3M |
|
|
EXE
356
Expand Energy Corporation Common Stock
EXE
$22.5B
| $265M | 0.06% |
2,268,718
-1,146,459
| -34% | -$134M |
|
357
Jones Lang LaSalle
JLL
$14.8B
| $265M | 0.06% |
1,036,382
+14,428
| +1% | +$3.69M |
|
358
Eastman Chemical
EMN
$7.91B
| $265M | 0.06% |
3,543,366
+955,035
| +37% | +$71.3M |
|
359
Edwards Lifesciences
EW
$47.1B
| $264M | 0.06% |
3,377,894
+180,902
| +6% | +$14.1M |
|
360
Thor Industries
THO
$5.92B
| $264M | 0.06% |
2,973,262
+13,715
| +0.5% | +$1.22M |
|
361
Corpay
CPAY
$22B
| $264M | 0.06% |
794,907
+24,635
| +3% | +$8.17M |
|
362
Dover
DOV
$24.4B
| $264M | 0.06% |
1,438,032
-103,376
| -7% | -$18.9M |
|
363
Canadian Natural Resources
CNQ
$63B
| $263M | 0.06% |
8,370,075
+87,067
| +1% | +$2.73M |
|
364
Stanley Black & Decker
SWK
$12.1B
| $263M | 0.06% |
3,876,777
+1,255,650
| +48% | +$85.1M |
|
365
Constellation Energy
CEG
$93.4B
| $262M | 0.06% |
812,692
-3,708
| -0.5% | -$1.2M |
|
366
Ryder
R
$7.67B
| $262M | 0.06% |
1,649,232
-17,489
| -1% | -$2.78M |
|
367
TTM Technologies
TTMI
$4.86B
| $262M | 0.06% |
6,419,219
-643,052
| -9% | -$26.2M |
|
368
Asbury Automotive
ABG
$5.06B
| $262M | 0.06% |
1,098,411
+9,234
| +0.8% | +$2.2M |
|
369
Essex Property Trust
ESS
$17.1B
| $262M | 0.06% |
923,704
-14,520
| -2% | -$4.12M |
|
370
Tenet Healthcare
THC
$17B
| $261M | 0.06% |
1,482,237
-192,962
| -12% | -$34M |
|
371
First Citizens BancShares
FCNCA
$25.2B
| $260M | 0.06% |
133,085
-3,422
| -3% | -$6.7M |
|
372
Lear
LEA
$6B
| $259M | 0.06% |
2,726,667
+95,190
| +4% | +$9.04M |
|
373
McKesson
MCK
$86.7B
| $259M | 0.06% |
352,815
-22,271
| -6% | -$16.3M |
|
374
Skywest
SKYW
$4.42B
| $258M | 0.06% |
2,509,688
-209,501
| -8% | -$21.6M |
|
375
NVR
NVR
$23.6B
| $258M | 0.06% |
34,967
+3,781
| +12% | +$27.9M |
|